Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-039324
Filing Date
2020-08-11
Accepted
2020-08-11 16:21:09
Documents
57
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q stsa-10q_20200630.htm 10-Q 2295664
2 EX-10.7 stsa-ex107_49.htm EX-10.7 102380
3 EX-31.1 stsa-ex311_9.htm EX-31.1 18869
4 EX-31.2 stsa-ex312_8.htm EX-31.2 18699
5 EX-32.1 stsa-ex321_6.htm EX-32.1 9905
6 EX-32.2 stsa-ex322_7.htm EX-32.2 9829
  Complete submission text file 0001564590-20-039324.txt   6606737

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT stsa-20200630.xml EX-101.INS 1288207
8 XBRL TAXONOMY EXTENSION SCHEMA stsa-20200630.xsd EX-101.SCH 40579
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE stsa-20200630_cal.xml EX-101.CAL 40640
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE stsa-20200630_def.xml EX-101.DEF 123812
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE stsa-20200630_lab.xml EX-101.LAB 326536
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE stsa-20200630_pre.xml EX-101.PRE 241000
Mailing Address 400 OYSTER POINT BOULEVARD SUITE 221 SOUTH SAN FRANCISCO CA 64080
Business Address 400 OYSTER POINT BOULEVARD SUITE 221 SOUTH SAN FRANCISCO CA 64080 415-505-0809
Satsuma Pharmaceuticals, Inc. (Filer) CIK: 0001692830 (see all company filings)

EIN.: 813039831 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39041 | Film No.: 201092699
SIC: 2834 Pharmaceutical Preparations